The 134th Yat-sen Life Sciences Lecture
Abstract1: C1 resources (CO₂, methane, methanol, formic acid, etc.) have attracted growing attention as feedstocks for biorefineries. Among them, methanol can be mass‑produced via CO₂ reduction powered by renewable energy such as solar energy. Featuring high energy density, convenient transportation and favorable liquid‑liquid mass transfer during fermentation, methanol holds great promise as an important biorefinery raw material. Nevertheless, its biological conversion efficiency is constrained by slow methanol metabolism, poorly understood regulatory mechanisms and inherent biological toxicity. Based on the research work of our group, this report will present research advances in constructing high-performance methanol‑utilizing yeast microbial cell factories for chemical synthesis using synthetic biology strategies. Particular focus is placed on the establishment of methanol‑oriented genetic manipulation platforms, enhancement of methanol metabolism and tolerance in yeast, and explorations toward efficient bioconversion of methanol into high‑value chemicals such as fatty acid derivatives.
Abstract2: Focused on synthetic biology and the development of smart living therapeutics, this report describes the design and construction of spatiotemporally tunable genetic circuits, optogenetic and small‑molecule‑regulated genetic tools, as well as the development of AAV delivery systems, engineered probiotics and cell therapy platforms. Targeting major diseases including metabolic disorders and tumors, programmable and reversibly‑regulated endogenous gene activation, smart cell‑based and living therapeutic systems are developed to realize on‑demand activation of therapeutic functions and precise dose titration. Animal model validation and translational research of candidate systems are also advanced, with the commitment to develop safe, controllable and new‑generation precision biotherapeutic technologies.
Abstract3: Synthetic biology is a cutting‑edge discipline grounded in biological science and integrated with engineering, information science, physics, chemistry and other subjects. It aims to engineer and systematically design, modify and even synthesize novel organisms to create artificial life with non‑natural functions. The core of synthetic biology lies in the "Design-Build-Test-Learn" cycle for microbial cell factories, which can drive high-quality development in fermentation engineering, food production, biopharmaceuticals, and other fields, serving as a critical engine for new quality productive forces. In recent years, high‑throughput sequencing technologies have expanded biological databases and generated massive biological omics data, laying a foundation for the advancement of big biological data and bioinformatics. As synthetic biology evolves, massive datasets have accumulated from key information and knowledge in element mining and design, as well as systematic optimization of metabolic networks and regulatory processes. Reliance solely on intuition and experience can no longer make effective use of multi‑source heterogeneous data and information.
Artificial intelligence represents a key component of the new round of scientific and technological revolution and a core driving force for industrial transformation. AI‑empowered synthetic biology has undergone rapid development, demonstrating tremendous potential especially in protein structure simulation and prediction, and the design and optimization of regulatory elements and metabolic networks. Promoting the integration of artificial intelligence into research on biomanufacturing of functional food ingredients conforms to cutting‑edge trends in synthetic biology and will facilitate in‑depth interdisciplinary convergence.


